Since the start of the year the All Ordinaries index has risen an impressive ~17.5% excluding dividends.
Whilst this is undoubtedly a strong gain, some constituents of the index have managed to vastly outperform it.
Three shares that have at least doubled in value in 2019 are listed below. Here’s why they are on fire:
The AVITA Medical Ltd (ASX: AVH) share price has been the best-performer on the index this year with a massive 425% gain. Investors have been buying the global regenerative medicine company’s shares due to the potential of its RECELL System. The RECELL System is a regeneration platform which was granted U.S. FDA approval last year as a Class III device for the treatment of acute thermal burns. At the end of the third quarter the company reported year to date sales of $11.5 million, which was an 86% increase on the prior corresponding period. Whilst this is strong growth, it is still only scratching at the surface of a U.S. market that management estimates to be worth US$5.7 billion per year.
The Bubs Australia Ltd (ASX: BUB) share price may have faded over the last few weeks but is still up a sizeable 102% since the start of the year. A series of positive developments have helped drive the baby food and infant formula company’s shares higher in 2019. These include an agreement with Chemist Warehouse, the acquisition of a manufacturing facility, and its expansion into cow milk infant formula. The latter was seen as a major positive as the cow milk formula market is materially bigger than the goat milk formula market, giving it a much larger addressable market. Bubs is targeting the premium side of the market and will offer an organic grass-fed range.
The Zip Co Ltd (ASX: Z1P) share price has rocketed 192% higher since the start of the year. The payments company has caught the eye of investors in 2019 thanks to an impressive first half result and equally strong third quarter result. In the third quarter Zip Co posted a 20% increase in quarterly revenue to a record $23 million. This was driven by the addition of several key retailers to its platform and another jump in customer numbers. During the quarter the company added a further 143,000 customers to its platform, taking its total to a sizeable 1.2 million.
Missed these stellar gains? Then don’t miss out on this hot stock before it pops.
One ASX Stock For An Estimated $US22 Billion Marijuana Market
A little-known ASX company just unlocked what some experts think could be the key to profiting off the coming marijuana boom.
And make no mistake – it is coming. To the tune of an estimated $US22 billion.
Cannabis legalisation is sweeping over North America, and full legalisation arrived in Canada in October 2018.
Here’s the best part: we think there’s one ASX stock that’s uniquely positioned to profit immensely from this explosive new industry… taking savvy investors along for what could be one heck of a ride.
AND, this is the first time The Motley Fool Australia has EVER put a BUY recommendation on a marijuana stock.
Simply click below to learn more on how you can profit from the coming cannabis boom.
Click here to find out more
James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of ZIPCOLTD FPO. The Motley Fool Australia has recommended BUBS AUST FPO. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
The Motley Fool’s purpose is to help the world invest, better. Click here now for your free subscription to Take Stock, The Motley Fool’s free investing newsletter. Packed with stock ideas and investing advice, it is essential reading for anyone looking to build and grow their wealth in the years ahead. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson. 2019